Oppenheimer Starts Antares Pharma (ATRS) at Outperform
Oppenheimer initiates coverage on Antares Pharma (NASDAQ: ATRS) with a Outperform. PT $6.00.
For an analyst ratings summary and ratings history on Antares Pharma click here. For more ratings news on Antares Pharma click here. Shares of Antares Pharma closed at $4.08 yesterday, with a 52 week range of $3.35-$5.58.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW *NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here begin ad tag (tile=12) -- End ad tag --